Latest News Releases From The Newsroom
Earnings Spotlight: Rapid7 Outperforms Estimates, Hyliion Falls Short
August 09th, 2023
Cybersecurity firm Rapid7, Inc. (Nasdaq: RPD) released its second-quarter 2023 financial report, disclosing earnings of $0.18 per share, exceeding the consensus EPS estimate of $0.11. The company's quarterly sales amounted to $190.42 million, slightl. Read more
Ups and Downs: Array Technologies Q2 Beats; Doximity Outlook Disappoints
August 09th, 2023
Array Technologies, Inc. (Nasdaq: ARRY) unveiled its second-quarter 2023 financial report, revealing earnings of $0.47 per share, surpassing the consensus EPS estimate of $0.18. The company's quarterly sales reached $507.70 million, exceeding the ana. Read more
Rocket Lab Posts Mixed Results, Seals Notable Deals; Rivian Beats Estimates
August 08th, 2023
Rocket Lab USA, Inc. (Nasdaq: RKLB) reported a second-quarter 2023 loss of $0.10 per share, which was slightly worse than the consensus estimate of a loss of $0.09 per share. However, revenues for the quarter totaled $62.05 million, slightly exceedin. Read more
SEC Charges 11 Wall Street Firms with Widespread Recordkeeping Failures
August 08th, 2023
Firms admit to wrongdoing and agree to pay penalties totaling $289 million FOR IMMEDIATE RELEASE 2023-149 Washington D.C. / CRWE PRESS RELEASE / Aug. 8, 2023 - The Securities and Exchange Commission today announced charges against 1. Read more
Market Surge: Nuburu's NASA Contract, Novavax's Surprise Profit
August 08th, 2023
Shares of Nuburu, Inc. (NYSE American: BURU) surged over 150% in pre-market trading as the company unveiled a groundbreaking contract with NASA. The contract is set to demonstrate the feasibility of NUBURU's innovative Blue Laser technology for po. Read more
Biophytis Gains Momentum; bluebird bio Posts Mixed Results
August 08th, 2023
Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program. This initiative marks the first-ever phase 3 study targ. Read more
Q2 Earnings: AMC Entertainment and RadNet Beat Expectations
August 08th, 2023
AMC Entertainment Holdings, Inc. (NYSE: AMC) has released its second-quarter 2023 financial report, surprising analysts with earnings per share (EPS) of $0.00 and revenues amounting to $1.35 billion. This outperformed the consensus forecast of a loss. Read more
Beyond Meat Posts Mixed Results; CRISPR Therapeutics Tops Estimates
August 08th, 2023
Beyond Meat, Inc. (Nasdaq: BYND) has reported a second-quarter 2023 loss of $0.83 per share, slightly better than the consensus estimated loss of $0.86 per share. However, quarterly revenues of $102.10 million fell short of the analysts' projected $1. Read more
Earnings Reaction Rollercoaster: Chegg Rises, Alteryx Dips
August 07th, 2023
Chegg, Inc. (NYSE: CHGG) announced second-quarter 2023 earnings per share (EPS) of $0.28 and revenues amounting to $182.85 million, surpassing the consensus EPS estimate of $0.29 on revenues of $176.51 million. $CHGG was trading at $12.45 in after. Read more
Breaking: Tyson Foods Q3 Misses Mark; Ginkgo Bioworks' Merck Deal Shakes Up
August 07th, 2023
Tyson Foods, Inc. (NYSE: TSN) has released its third-quarter fiscal 2023 financial results, reporting adjusted earnings per share (EPS) of $0.15 and revenues totaling $13.14 billion. These figures fell short of market consensus estimates of $0.26 EPS. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login